Liverpool University Biobank

• Research type

  Research Tissue Bank

• IRAS ID

  250168

• Research summary

  Liverpool University Biobank

• REC name

  North West - Liverpool Central Research Ethics Committee

• REC reference

  18/NW/0771

• Date of REC Opinion

  8 Jan 2019

• REC opinion

  Further Information Favourable Opinion

• Data collection arrangements

  Collections will include, but not limited to blood, tissue, urine, saliva, sputum, lung fluids, pleural effusion, ascites, cerebrospinal fluid, vitreous and faeces. Relevant clinical data from a variety of sources relating to the patient will also be collected and stored in the Biobank. The data will be securely stored within the Biobank on a password protected database. Only Biobank authorised staff members will have access to the database and are responsible for its updating and maintenance. All samples will be coded with a unique identifier and only Biobank staff will be able to link samples with a specific number to an individual donor. Potential donors will be first approached while they are attending scheduled outpatient clinic appointments or inpatient admissions by a member of the clinical care team directly involved in the patient's care. The patient will be given a patient information booklet and consent form to read describing the work of the Biobank and what donation would involve. If the patient is willing to donate a biological sample, the Biobank will coordinate their clinical team to obtain the patients’ samples and transfer back to the Biobank for processing and storage.

• Research programme

  The Liverpool University Biobank supports a large research community within the University but is also open to other academic institutions and commercial organisations based in the UK and abroad. It is intended that research will include studies of the impact of environmental risk exposures on health, understanding risks for diseases, identification of biomarkers in disease progression, prognosis, response to treatment, and implementation of personalized medicine into clinical practice. Genetic research will be used in order to develop improved tools for establishing prognostic and predictive factors influencing response to treatment. Access to samples is only possible after a thorough review by the Liverpool University Biobank Governance and Ethics Group.

• Storage license

  12020

• RTBTitle

  Liverpool University Biobank

• Establishment organisation

  University of Liverpool

• Establishment organisation address

  Department of Musculoskeletal and Ageing Science

  North West Cancer Research Centre

  200 London Road, Liverpool

  L3 9TA